TRIM33 and hepatocellular carcinoma: While the function of TRIM33 in cancer has not been fully elucidated, it has been identified as a tumour suppressor in several cancer types, including chronic myelomonocytic leukaemia (CMML) and hepatocellular cancer, where TRIM33 is downregulated through hypermethylation of its promoter region20,21.